Skip to main content
Top
Published in: Lasers in Medical Science 1/2014

01-01-2014 | Original Article

Treatment of superficial vascular lesions with the KTP 532-nm laser: experience with 647 patients

Authors: G. L. Becher, H. Cameron, H. Moseley

Published in: Lasers in Medical Science | Issue 1/2014

Login to get access

Abstract

Superficial vascular lesions are a common dermatological diagnosis but are often difficult to treat. Numerous lasers (especially the dye laser) and intense pulsed light sources have been used, but there have been very few reports on the effectiveness of the potassium-titanyl phosphate (KTP) laser. We have extensive experience of this modality at our institution, and the purpose of this survey is to report on the safety and efficacy of the KTP laser. Using an in-house database, we retrospectively collected data from patients who had undergone treatment with the KTP laser for superficial vascular lesions. Patients of Fitzpatrick skin type I–IV were included. Exclusion criteria were Fitzpatrick skin type V, patients with obvious suntan and those on potentially phototoxic medications or minocycline therapy. Diagnoses included discrete or matted telangiectasia, strawberry naevus, spider angioma, rosaceal erythema, rosaceal telangiectasia, telangiectatic naevus, angioma, combined rosaceal erythema/telangiectasia, port-wine stain, venous lake haemangioma and hereditary haemorrhagic telangiectasia. Patients underwent an initial test treatment and further treatment at 6-week intervals as required. Clinical photographs were taken pre- and post-treatment, and outcome was graded by patient and physician. Adverse effects were recorded including scarring, hypo- or hyperpigmentation, marked swelling, blistering, scabbing and bruising. Six hundred forty-seven patients with 13 diagnoses on 9 different body sites were recorded. Four hundred eighty-six were female, and the median age was 39.5 years. Of the lesions treated, 33.7 % (n = 218) were discrete telangiectases and 31.8 % (n = 206) were spider angiomas. A 92.7 % of lesions were on the face. Four hundred thirteen (77.6 %) patients who had outcomes recorded at 6 weeks were graded as “clearance” or “marked improvement”. Only 38 (5.8 %) patients experienced adverse effects, all of which were minor; the main adverse effect was swelling. Unlike the dye laser, there was only one case of bruising out of 647 patients. This is the largest survey of patients to have undergone KTP laser treatment reported in the literature. Our results show that the KTP laser is a safe and effective modality for the treatment of superficial vascular lesions.
Literature
1.
go back to reference Gupta G, Bilsland D (2000) A prospective study of the impact of laser treatment on vascular lesions. Br J Dermatol 143:356–359PubMedCrossRef Gupta G, Bilsland D (2000) A prospective study of the impact of laser treatment on vascular lesions. Br J Dermatol 143:356–359PubMedCrossRef
2.
go back to reference Shakespeare V, Shakespeare P, Cole RP (1998) Measuring patient satisfaction with pulsed dye laser treatment of vascular lesions. Lasers Med Sci 13:253–259CrossRef Shakespeare V, Shakespeare P, Cole RP (1998) Measuring patient satisfaction with pulsed dye laser treatment of vascular lesions. Lasers Med Sci 13:253–259CrossRef
3.
go back to reference Anderson RR, Parrish JA (1983) Selective photothermolysis: precise microsurgery by selective absorption of pulsed radiation. Science 220:524–527PubMedCrossRef Anderson RR, Parrish JA (1983) Selective photothermolysis: precise microsurgery by selective absorption of pulsed radiation. Science 220:524–527PubMedCrossRef
4.
go back to reference Anderson RR, Parrish JA (1981) Microvasculature can be selectively damaged using dye lasers: a basic theory and experimental evidence in human skin. Lasers Surg Med 1:263–276PubMedCrossRef Anderson RR, Parrish JA (1981) Microvasculature can be selectively damaged using dye lasers: a basic theory and experimental evidence in human skin. Lasers Surg Med 1:263–276PubMedCrossRef
5.
go back to reference Tan OT, Whitaker D, Garden JM, Murphy G (1988) Pulsed dye laser (577 nm) treatment of portwine stains: ultrastructural evidence of neovascularization and mast cell degranulation in healed lesions. J Invest Dermatol 90:395–398PubMedCrossRef Tan OT, Whitaker D, Garden JM, Murphy G (1988) Pulsed dye laser (577 nm) treatment of portwine stains: ultrastructural evidence of neovascularization and mast cell degranulation in healed lesions. J Invest Dermatol 90:395–398PubMedCrossRef
6.
go back to reference Woo S, Ahn H, Kim S, Kye Y (2006) Treatment of vascular skin lesions with the variable pulse 595 nm pulsed dye laser. Dermatol Surg 32:41–48PubMedCrossRef Woo S, Ahn H, Kim S, Kye Y (2006) Treatment of vascular skin lesions with the variable pulse 595 nm pulsed dye laser. Dermatol Surg 32:41–48PubMedCrossRef
7.
go back to reference Tan OT, Sherwood K, Gilchrist BA (1989) Treatment of children with port-wine stains using the flashlamp pulsed tunable dye laser. N Engl J Med 320:416–421PubMedCrossRef Tan OT, Sherwood K, Gilchrist BA (1989) Treatment of children with port-wine stains using the flashlamp pulsed tunable dye laser. N Engl J Med 320:416–421PubMedCrossRef
8.
go back to reference Adrian RM, Tangehetti EA (1998) Long pulse 532-nm laser treatment of facial telangiectasia. Dermatol Surg 24:71–74PubMed Adrian RM, Tangehetti EA (1998) Long pulse 532-nm laser treatment of facial telangiectasia. Dermatol Surg 24:71–74PubMed
9.
go back to reference Seukeran DC, Collins P, Sheehan-Dare RA (1997) Adverse reactions following pulsed tunable dye laser treatment of port wine stains in 701 patients. Br J Dermatol 136:725–729PubMedCrossRef Seukeran DC, Collins P, Sheehan-Dare RA (1997) Adverse reactions following pulsed tunable dye laser treatment of port wine stains in 701 patients. Br J Dermatol 136:725–729PubMedCrossRef
10.
go back to reference Goldberg DJ (2000) Laser treatment of vascular lesions. Clin Plastic Surg 27:173–180 Goldberg DJ (2000) Laser treatment of vascular lesions. Clin Plastic Surg 27:173–180
11.
go back to reference Cameron H, Ibbotson SH, Ferguson J, Dawe RS, Moseley H (2005) A randomised, blinded, controlled study of the clinical relevance of matching pulse duration to thermal relaxation time when treating facial telangiectasia. Lasers Med Sci 20:117–121PubMedCrossRef Cameron H, Ibbotson SH, Ferguson J, Dawe RS, Moseley H (2005) A randomised, blinded, controlled study of the clinical relevance of matching pulse duration to thermal relaxation time when treating facial telangiectasia. Lasers Med Sci 20:117–121PubMedCrossRef
12.
go back to reference Clark C, Cameron H, Moseley H, Ferguson J et al (2004) Treatment of superficial cutaneous vascular lesions: experience with the KTP 532 nm laser. Lasers Med Sci 19:1–5PubMedCrossRef Clark C, Cameron H, Moseley H, Ferguson J et al (2004) Treatment of superficial cutaneous vascular lesions: experience with the KTP 532 nm laser. Lasers Med Sci 19:1–5PubMedCrossRef
13.
go back to reference West TB, Alster TS (1998) Comparison of the long-pulse dye (590–595 nm) and KTP (532 nm) lasers in the treatment of facial and leg telangiectasias. Dermatol Surg 24:221–226PubMed West TB, Alster TS (1998) Comparison of the long-pulse dye (590–595 nm) and KTP (532 nm) lasers in the treatment of facial and leg telangiectasias. Dermatol Surg 24:221–226PubMed
14.
go back to reference Cassuto DA, Ancona DM, Emanuelli G (2000) Treatment of facial telangiectasias with a diode-pumped Nd:YAG laser at 532 nm. J Cosmet Laser Ther 3:141–146CrossRef Cassuto DA, Ancona DM, Emanuelli G (2000) Treatment of facial telangiectasias with a diode-pumped Nd:YAG laser at 532 nm. J Cosmet Laser Ther 3:141–146CrossRef
15.
go back to reference Fenske NA, Millns JL, Greer KE (1980) Minocycline-induced pigmentation at sites of cutaneous inflammation. J Am Med Assoc 244:1103–1106CrossRef Fenske NA, Millns JL, Greer KE (1980) Minocycline-induced pigmentation at sites of cutaneous inflammation. J Am Med Assoc 244:1103–1106CrossRef
16.
go back to reference Vesnaver A, Dovsak DA (2009) Treatment of large vascular lesions in the orofacial region with the Nd:YAG laser. J Cranio-Max Surg 37:191–195CrossRef Vesnaver A, Dovsak DA (2009) Treatment of large vascular lesions in the orofacial region with the Nd:YAG laser. J Cranio-Max Surg 37:191–195CrossRef
17.
go back to reference Chowdhury MM, Harris S, Lanigan SW (2001) Potassium titanyl phosphate laser treatment of resistant port-wine stains. Br J Dermatol 144:814–817PubMedCrossRef Chowdhury MM, Harris S, Lanigan SW (2001) Potassium titanyl phosphate laser treatment of resistant port-wine stains. Br J Dermatol 144:814–817PubMedCrossRef
18.
go back to reference Tierney E, Hanke W (2009) Randomized controlled trial: comparative efficacy for the treatment of facial telangiectasias with 532 nm versus 940 nm diode laser. Lasers Surg Med 41:555–562PubMedCrossRef Tierney E, Hanke W (2009) Randomized controlled trial: comparative efficacy for the treatment of facial telangiectasias with 532 nm versus 940 nm diode laser. Lasers Surg Med 41:555–562PubMedCrossRef
19.
go back to reference Werner A, Baumler W, Zietz S, Kuhnel T, Hohenleutner U (2008) Hereditary haemorrhagic telangiectasia treated by pulsed neodymium:yttrium-aluminium-garnet (Nd:YAG) laser (1,064 nm). Lasers Med Sci 23:385–391PubMedCrossRef Werner A, Baumler W, Zietz S, Kuhnel T, Hohenleutner U (2008) Hereditary haemorrhagic telangiectasia treated by pulsed neodymium:yttrium-aluminium-garnet (Nd:YAG) laser (1,064 nm). Lasers Med Sci 23:385–391PubMedCrossRef
20.
go back to reference Galeckas KJ (2008) Update on lasers and light devices for the treatment of vascular lesions. Semin Cutan Med Surg 27:276–284PubMedCrossRef Galeckas KJ (2008) Update on lasers and light devices for the treatment of vascular lesions. Semin Cutan Med Surg 27:276–284PubMedCrossRef
21.
go back to reference Bencini PL, Toulaki A, De Giiorgi V, Galimberti M (2012) Laser use for cutaneous vascular alterations of cosmetic interest. Derm Ther 25:340–351CrossRef Bencini PL, Toulaki A, De Giiorgi V, Galimberti M (2012) Laser use for cutaneous vascular alterations of cosmetic interest. Derm Ther 25:340–351CrossRef
22.
go back to reference Franca K, Chacon A, Ledon J, Savas J, Izakovic J, Nouri K (2012) Lasers for cutaneous congenital vascular lesions: a comprehensive overview and update. Lasers Med Sci (PMID:23093134) Franca K, Chacon A, Ledon J, Savas J, Izakovic J, Nouri K (2012) Lasers for cutaneous congenital vascular lesions: a comprehensive overview and update. Lasers Med Sci (PMID:23093134)
Metadata
Title
Treatment of superficial vascular lesions with the KTP 532-nm laser: experience with 647 patients
Authors
G. L. Becher
H. Cameron
H. Moseley
Publication date
01-01-2014
Publisher
Springer London
Published in
Lasers in Medical Science / Issue 1/2014
Print ISSN: 0268-8921
Electronic ISSN: 1435-604X
DOI
https://doi.org/10.1007/s10103-013-1330-5

Other articles of this Issue 1/2014

Lasers in Medical Science 1/2014 Go to the issue